Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (811-820 of 13,985) with videos related to

Pageof 1,399
Sort By:
Leukemia|September 10, 2010
B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cellsE Gross, F-E L'Faqihi-Olive, L Ysebaert, et al.
Leukemia|September 10, 2010
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantationS Thepot, J Zhou, A Perrot, et al.
Leukemia|September 3, 2010
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemiaH Andrikovics, S Nahajevszky, M Koszarska, et al.
Leukemia|September 3, 2010
OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1D L White, V A Saunders, P Dang, et al.
Leukemia|October 22, 2010
A nonsense mutation of IDH1 in myelodysplastic syndromes and related disordersK Yoshida, M Sanada, M Kato, et al.
Leukemia|November 6, 2010
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitroJ Iqbal, D D Weisenburger, A Chowdhury, et al.
Leukemia|September 17, 2010
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activationA C Sprynski, D Hose, A Kassambara, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|September 17, 2010
Mixed-phenotype acute leukemia: historical overview and a new definitionO K Weinberg, D A Arber
Leukemia|November 27, 2010
Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromesM Y Follo, C Finelli, S Mongiorgi, et al.
Pageof 1,399

Showing results (811-820 of 13,985) with videos related to

Sort By:
Pageof 1,399
Leukemia|September 10, 2010
B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cellsE Gross, F-E L'Faqihi-Olive, L Ysebaert, et al.
Leukemia|September 10, 2010
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantationS Thepot, J Zhou, A Perrot, et al.
Leukemia|September 3, 2010
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemiaH Andrikovics, S Nahajevszky, M Koszarska, et al.
Leukemia|September 3, 2010
OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1D L White, V A Saunders, P Dang, et al.
Leukemia|October 22, 2010
A nonsense mutation of IDH1 in myelodysplastic syndromes and related disordersK Yoshida, M Sanada, M Kato, et al.
Leukemia|November 6, 2010
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitroJ Iqbal, D D Weisenburger, A Chowdhury, et al.
Leukemia|September 17, 2010
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activationA C Sprynski, D Hose, A Kassambara, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|September 17, 2010
Mixed-phenotype acute leukemia: historical overview and a new definitionO K Weinberg, D A Arber
Leukemia|November 27, 2010
Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromesM Y Follo, C Finelli, S Mongiorgi, et al.
Pageof 1,399